Krystal Y Chung1, Jessica C S Brown1. 1. Division of Microbiology and Immunology, Pathology Department, University of Utah School of Medicine, Salt Lake City, UT 84112, USA.
Abstract
PURPOSE OF REVIEW: Environmental fungi such as Cryptococcus neoformans and Aspergillus fumigatus must survive many different and changing environments as they transition from their environmental niches to human lungs and other organs. Fungi alter their cell surfaces and secreted macromolecules to respond to and manipulate their surroundings. RECENT FINDINGS: This review focuses on exo-polysaccharides, chains of sugars that transported out of the cell and spread to the local environment. Major exo-polysaccharides for C. neoformans and A. fumigatus are glucuronylxylomannan (GXM) and galactosaminogalactan (GAG), respectively, which accumulate at high concentrations in growth medium and infected patients. SUMMARY: Here we discuss GXM and GAG synthesis and export, their immunomodulatory properties, and their roles in biofilm formation. We also propose areas of future research to address outstanding questions in the field that could facilitate development of new disease treatments.
PURPOSE OF REVIEW: Environmental fungi such as Cryptococcus neoformans and Aspergillus fumigatus must survive many different and changing environments as they transition from their environmental niches to human lungs and other organs. Fungi alter their cell surfaces and secreted macromolecules to respond to and manipulate their surroundings. RECENT FINDINGS: This review focuses on exo-polysaccharides, chains of sugars that transported out of the cell and spread to the local environment. Major exo-polysaccharides for C. neoformans and A. fumigatus are glucuronylxylomannan (GXM) and galactosaminogalactan (GAG), respectively, which accumulate at high concentrations in growth medium and infected patients. SUMMARY: Here we discuss GXM and GAG synthesis and export, their immunomodulatory properties, and their roles in biofilm formation. We also propose areas of future research to address outstanding questions in the field that could facilitate development of new disease treatments.
Authors: Bryan Coburn; Pauline W Wang; Julio Diaz Caballero; Shawn T Clark; Vijaya Brahma; Sylva Donaldson; Yu Zhang; Anu Surendra; Yunchen Gong; D Elizabeth Tullis; Yvonne C W Yau; Valerie J Waters; David M Hwang; David S Guttman Journal: Sci Rep Date: 2015-05-14 Impact factor: 4.379
Authors: Emma J Robertson; Grace Najjuka; Melissa A Rolfes; Andrew Akampurira; Neena Jain; Janani Anantharanjit; Maximilian von Hohenberg; Manlio Tassieri; Allan Carlsson; David B Meya; Thomas S Harrison; Bettina C Fries; David R Boulware; Tihana Bicanic Journal: J Infect Dis Date: 2013-08-14 Impact factor: 5.226
Authors: Mark J Lee; Alexander M Geller; Natalie C Bamford; Hong Liu; Fabrice N Gravelat; Brendan D Snarr; François Le Mauff; Joseé Chabot; Benjamin Ralph; Hanna Ostapska; Mélanie Lehoux; Robert P Cerone; Stephanie D Baptista; Evgeny Vinogradov; Jason E Stajich; Scott G Filler; P Lynne Howell; Donald C Sheppard Journal: MBio Date: 2016-04-05 Impact factor: 7.867
Authors: Giuseppe Carota; Simone Ronsisvalle; Federica Panarello; Daniele Tibullo; Anna Nicolosi; Giovanni Li Volti Journal: J Clin Med Date: 2021-05-25 Impact factor: 4.241